|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.22 CHF | +3.87% |
|
+2.75% | -2.00% |
| 02:15am | Cerebras prices IPO at $185 per share to raise $5.55 billion | RE |
| 05-13 | Easing medical costs a positive for health insurers, but real test lies ahead, analysts say | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 37.12 | 38.17 | 38.15 |
| Spread/Res. | -2.42% | -5.11% | -5.06% |
| Spread/Supp. | +7.99% | +24.55% | +45.35% |
| Support | 33.54 | 29.08 | 24.92 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UBSG Stock
- Charts UBS Group AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition